Gene Synthesis from 0.79/bp

Buy now at our best rate ever.
> get a quote

NEWS

GENEART AG Presents Financial Statements for 2007 and Preliminary Results for the First Quarter 2008

> more

The US National Cancer Institute Extends its Contract with GENEART – Order Volume USD 1.9M

> more

GENEART is Awarded a European Patent for Successfully Tested HIV Vaccines

> more

CUSTOMER STATEMENTS

» Thank you so much for the excellent service GENEART provided us with. It was very fast and the service of providing the actual DNA with a CD that contains all the data is exceptional !!!!!! Everything was done in a very professional way and whenever I will be asked by somebody about a service you might provide I will definitely recommend GENEART. «

West Coast Biotech

GENEART is the solution provider for DNA engineering and processing in the field of improved medicine and biotechnology.
As the world wide leading supplier for synthetic genes, we deliver services to academia and industry, which comprise:

Your advantages:

system solutions in DNA engineering and processing for improved drugs and biotech products
outstanding service quality
(certified by external audits and according to ISO 9001:2000)
highest production capacity in industry
highest security levels for confidential customer data
proprietary optimization and production process

GENEART is listed on Frankfurt stock exchange, ISIN: DE000A0JJ4L4 and thus the first publicly listed gene synthesis company world wide. This access to the capital market reflects our binding commitment to market and technology leadership.